Cipla

Ashwani Gujral: BUY Cipla, Biocon; SELL Axis Bank, Bajaj Finance and Prestige Estate

Ashwani Gujral: BUY Cipla, Biocon; SELL Axis Bank, Bajaj Finance and Prestige Estate

Ashwani Gujral: BUY IndusInd Bank, SBI, Kotak Mahindra Bank, Sun Pharma and Godrej Consumer

Ashwani Gujral: BUY IndusInd Bank, SBI, Kotak Mahindra Bank, Sun Pharma and Godrej Consumer

Market analyst Ashwani Gujral has suggested five BUY Calls and no SELL calls for today’s trade, suggesting a bullish view for bounce-back in Indian markets after yesterday’s decline.

Ashwani Gujral: BUY Cipla, Dr Reddy’s, Tata Steel, UPL and Bharti Infratel

Ashwani Gujral: BUY Cipla, Dr Reddy’s, Tata Steel, UPL and Bharti Infratel

Market analyst Ashwani Gujral has suggested five BUY calls and no SELL call for today’s session, suggesting a bullish outlook for markets.

Sanjiv Bhasin IIFL Securities: Lupin, Cipla, IPCA Labs, Cadila and Dr Lal Path Labs look interesting

Sanjiv Bhasin IIFL Securities: Lupin, Cipla, IPCA Labs, Cadila and Dr Lal Path Labs look interesting

Market expert Sanjiv Bhasin has suggested five stocks for investors and medium-term outlook traders for August in the pharmaceutical segment.

Controversy about Gilead’s Remdesivir in India due to low production and black market sale

Controversy about Gilead’s Remdesivir in India due to low production and black market sale

Gilead Sciences signed a contract with four Indian pharmaceutical companies to produce its medication ‘Remdesivir’ which has been found effective in treatment of some COVID-19 patients.

Ashwani Gujral Trading Call Performance for Hero MotoCorp, Tata Steel, Titan, Cipla and HCL Technologies

Ashwani Gujral Trading Call Performance for Hero MotoCorp, Tata Steel, Titan, Cipla and HCL Technologies

Market analyst Ashwani Gujral suggested five BUY Calls and no SELL call for today’s session and TopNews has reviewed the trading call performance for today’s session Indian markets firmed up on Fri

Pages